In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.

Allergy and Respiratory Research Group Usher Institute of Population Health Sciences and Informatics University of Edinburgh Edinburgh United Kingdom

Allergy Royal Brompton Hospital London United Kingdom

Allergy Unit Department of Dermatology University Hospital Zurich Zurich Switzerland

Christine Kühne Center for Allergy research and Education CK CARE Davos Switzerland

Department Clinical Pharmacy and Pharmacology University of Groningen University Medical Center Groningen Groningen Netherlands

Department of Allergy and Rhinology Royal National ENT Hospital London United Kingdom

Department of Clinical Medicine University of Aarhus Aarhus Denmark

Department of Clinical Science and Education Södersjukhuset Karolinska Institutet and Sachs' Children and Youth Hospital Stockholm Sweden

Department of Dermatology University of Zurich Zurich Switzerland

Department of Dermatology Venereology and Leprology Post Graduate Institute of Medical Education and Research Chandigarh India

Department of Otolaryngology and Head and Neck Surgery Eastern Virginia Medical School Norfolk VA United States

Department of Otorhinolaryngology Amsterdam University Medical Centres Amsterdam Netherlands

Department of Otorhinolaryngology and Center for Allergy and Environment TUM School of Medicine Klinikum rechts der Isar Technical University of Munich Munich Germany

Department of Otorhinolaryngology Head and Neck Surgery and Audiology Rigshospitalet Copenhagen University Copenhagen Denmark

Department of Otorhinolaryngology Head and Neck Surgery University Hospitals Leuven Belgium

Department of Pediatric Respiratory Medicine Immunology and Critical Care Medicine Charité Universitaetsmedizin Berlin Germany

Department of Pulmonology and Phthisiology Department of Pediatrics Department of Clinical Immunology and Allergology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava University Hospital in Martin Martin Slovakia

Department of Respiratory Medicine 1st Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Respiratory Medicine and Allergology Institute for Clinical Science Skane University Hospital Lund University Lund Sweden

Dept of Microbiology Immunology and Transplantation KU Leuven Catholic University of Leuven Leuven Belgium

Division of Allergy Department of Paediatrics and Child Health University of Cape Town Rondebosch South Africa

Division of Immunity and Infection University College London United Kingdom

International Primary Care Respiratory Group Edinburgh United Kingdom

Mediclinic Sandton Johannesburg South Africa

NIHR Southampton Biomedical Research Centre Faculty of Medicine University of Southampton Southampton United Kingdom

Otolaryngology Head and Neck Surgery A Gemelli University Hospital Foundation IRCCS Rome Italy

Patient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases Brussels Belgium

Rhinology Unit and Smell Clinic ENT Department Hospital Clínic FRCB IDIBAPS Universitat de Barcelona CIBERES Barcelona Catalonia Spain

Specialist Allergist Kidsallergy Centre Cape Town South Africa

The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members Brussels Belgium

Upper Airways Research Laboratory Department of Head and Skin Ghent University Ghent Belgium

Wellcome Wolfson Institute for Experimental Medicine Queens University Belfast Belfast United Kingdom

See more in PubMed

Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C, et al. European summit on the prevention and self-management of chronic respiratory diseases: report of the European union parliament summit (29 march 2017). Clin Transl Allergy. (2017) 27(7):49. 10.1186/s13601-017-0186-3 PubMed DOI PMC

Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA. Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Allergy Clin Immunol Pract. (2022) 10(6):1434–1453.e9. 10.1016/j.jaip.2022.03.002 PubMed DOI

Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. (2020) 58(Suppl S29):1–464. 10.4193/Rhin20.600 PubMed DOI

De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, et al. White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA. Front Allergy. (2022) 2(3):889221. 10.3389/falgy.2022.889221 PubMed DOI PMC

GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. (2020) 8(6):585–96. 10.1016/S2213-2600(20)30105-3 PubMed DOI PMC

Claeys N, Teeling MT, Legrand P, Poppe M, Verschueren P, De Prins L, et al. Patients unmet needs in chronic rhinosinusitis with nasal polyps care: a patient advisory board statement of EUFOREA. Front Allergy. (2021) 29(2):761388. 10.3389/falgy.2021.761388 PubMed DOI PMC

Pugin B, Deneyer L, Bachert C, Alobid I, Bousquet J, De Carlo G, et al. Patient advisory board for chronic rhinosinusitis—a EUFOREA initiative. Rhinology. (2019) 57(5):331–5. 10.4193/Rhin19.012 PubMed DOI

Bachert C, Han JK, Wagenmann M, Hosemann W, Lee SE, Backer V, et al. EUFOREA Expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. (2021) 147(1):29–36. 10.1016/j.jaci.2020.11.013 PubMed DOI

Bourdin A, Bjermer L, Brightling C, Brusselle GG, Chanez P, Chung KF, et al. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Eur Respir J. (2019) 54(3):1900900. 10.1183/13993003.00900-2019 PubMed DOI

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. (2020) 396(10258):1204–22. 10.1016/S0140-6736(20)30925-9 PubMed DOI PMC

Hellings PW, Fokkens WJ, Orlandi R, Adriaensen GF, Alobid I, Baroody FM, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhinology. (2023) 61(1):85–9. 10.4193/Rhin22.344 PubMed DOI

Hellings PW, Scadding G, Bachert C, Bjermer L, Canonica GW, Cardell LO, et al. EUFOREA Treatment algorithm for allergic rhinitis. Rhinology. (2020) 58(6):618–22. 10.4193/Rhin20.376 PubMed DOI

Scadding GK, Smith PK, Blaiss M, Roberts G, Hellings PW, Gevaert P, et al. Allergic rhinitis in childhood and the new EUFOREA algorithm. Front Allergy. (2021) 14(2):706589. 10.3389/falgy.2021.706589 PubMed DOI PMC

Ryan D, Keighley A, Jackson T. Patient perspectives in asthma: listening to and learning from a new paradigm in translational research. Respir Med. (2022) 205:107013. 10.1016/j.rmed.2022.107013 PubMed DOI

Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k guideline of the German society for allergology and clinical immunology (DGAKI), the society for pediatric allergy and environmental medicine (GPA), the medical association of German allergologists (AeDA), the Austrian society for allergy and immunology (ÖGAI), the Swiss society for allergy and immunology (SGAI), the German society of dermatology (DDG), the German society of Oto- rhino-laryngology, head and neck surgery (DGHNO-KHC), the German society of pediatrics and adolescent medicine (DGKJ), the society for pediatric pneumology (GPP), the German respiratory society (DGP), the German association of ENT surgeons (BV-HNO), the professional federation of paediatricians and youth doctors (BVKJ), the federal association of pulmonologists (BDP) and the German dermatologists association (BVDD). Allergo J Int. (2014) 23(8):282–319. 10.1007/s40629-014-0032-2 PubMed DOI PMC

Alanin MC, Hopkins C. Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis. Curr Allergy Asthma Rep. (2020) 20(7):27. 10.1007/s11882-020-00932-6 PubMed DOI

Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. (2011) 378(9809):2112–22. 10.1016/S0140-6736(11)60130-X PubMed DOI

Diamant Z, van Maaren M, Muraro A, Jesenak M, Striz I. Allergen immunotherapy for allergic asthma: the future seems bright. Respir Med. (2023) 210:107125. 10.1016/j.rmed.2023.107125 PubMed DOI

Biermann J, Merk HF, Wehrmann W, Klimek L, Wasem J. Allergic disorders of the respiratory tract—findings from a large patient sample in the German statutory health insurance system. Allergo J. (2013) 22:366–73. 10.1007/s15007-013-0350-6 DOI

Pfaar O, Richter H, Sager A, Miller C, Müller T, Jutel M. Persistence in allergen immunotherapy: a longitudinal, prescription data-based real-world analysis. Clin Transl Allergy. (2023) 13(5):e12245. 10.1002/clt2.12245 PubMed DOI PMC

Šošić L, Paolucci M, Flory S, Jebbawi F, Kündig TM, Johansen P. Allergen immunotherapy: progress and future outlook. Expert Rev Clin Immunol. (2023) 19(7):745–69. 10.1080/1744666X.2023.2209319 PubMed DOI

Melén E, Koppelman GH, Vicedo-Cabrera AM, Andersen ZJ, Bunyavanich S. Allergies to food and airborne allergens in children and adolescents: role of epigenetics in a changing environment. Lancet Child Adolesc Health. (2022) 6(11):810–19. 10.1016/S2352-4642(22)00215-2 PubMed DOI

Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhinology. (2021) 59(2):151–63. 10.4193/Rhin20.570 PubMed DOI

Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. (2022) 386(2):157–71. 10.1056/NEJMra2032506 PubMed DOI

Striz I, Golebski K, Strizova Z, Loukides S, Bakakos P, Hanania NA, et al. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. Clin Sci. (2023) 137(9):727–53. 10.1042/CS20190281 PubMed DOI PMC

Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, et al. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med. (2023) 21. 10.1056/NEJMoa2303951 PubMed DOI

Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. (2023) 61(3):194–202. 10.4193/Rhin22.489 PubMed DOI

Mullol J, Maldonado M, Castillo JA, Miguel-Blanco C, Dávila I, Domínguez-Ortega J, et al. Management of united airway disease focused on patients with asthma and chronic rhinosinusitis with nasal polyps: a systematic review. J Allergy Clin Immunol Pract. (2022) 10(9):2438–2447.e9. 10.1016/j.jaip.2022.04.039 PubMed DOI

Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthma